17 results
8-K
INGN
Inogen Inc
15 Apr 24
Departure of Directors or Certain Officers
4:15pm
of Executive Vice President, R&D and Chief Medical Officer
On April 11, 2024, Inogen, Inc. (the “Company”) and Dr. Stanislav Glezer, Executive Vice … President, R&D and Chief Medical Officer of the Company, mutually determined that Dr. Glezer would separate from the Company on or before May 3, 2024
8-K
EX-99.1
INGN
Inogen Inc
24 Feb 22
Inogen Announces Fourth Quarter and Full Year 2021 Financial Results
4:06pm
research and R&D capabilities and commercial strategies that will position us for long-term, sustainable growth and profitability in the years to come
8-K
EX-99.2
mbqbt37wm8xif
10 Jan 22
Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2021 Revenue Results
7:04am
8-K
EX-99.1
lhluee7x2clhpkgb025
11 Jan 21
Regulation FD Disclosure
6:02am
8-K
EX-99.2
ge9otup b68
13 Jan 20
Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2019 Revenue Results
8:01am
8-K
EX-99.1
62ezdlvvc8e78q03
9 Sep 19
Regulation FD Disclosure
6:04am
8-K
EX-99.1
246l2r 1t7koxe6
7 Jan 19
Regulation FD Disclosure
6:09am
- Prev
- 1
- Next